Vanberra Signal

Diabeloop

Curated by Signal

Developer of AI-based blood sugar monitoring device

Overview

Developer of AI-based blood sugar monitoring device. The device is a DBLG1 that serves as a user interface with the system and is associated with a continuous glucose sensor and an insulin pump. The sensor sends the blood glucose results at periodic intervals to the DBLG1 and it analyzes the results and calculates the right dose of insulin to be administered. This device is used for the treatment of type one diabetes in adults.

Key facts

Founded
2015
Headquarters
Grenoble, France

Business model

Contact

Open roles

4 roles
  • Chercheur / Data Scientist (H/F)

    Grenoble, Auvergne-Rhône-Alpes, France · On-site · Volunteer

  • Spécialiste Formation / Training Specialist F/H

    Grenoble, Auvergne-Rhône-Alpes, France · On-site · Full-time

  • Assurance Qualité et Affaires Réglementaires Leader (F/H)

    Grenoble, Auvergne-Rhône-Alpes, France · Hybrid · Full-time

+ 1 more open role on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of DNA tests for certification of origin and prevention of diseases in pets

    Life Sciences TechnologyLyon, France
  • Provider of solution for restoring ovulation in PCOS patients

    Life Sciences TechnologyParis, France
  • Provider of software for research purpose

    Life Sciences TechnologyColombes, France

About Diabeloop

What does Diabeloop do?

Developer of AI-based blood sugar monitoring device.

Where is Diabeloop headquartered?

Diabeloop is headquartered in Grenoble, France.

When was Diabeloop founded?

Diabeloop was founded in 2015.

Which sector is Diabeloop in?

Diabeloop operates in Life Sciences Technology.

Who are Diabeloop's competitors?

Companies similar to Diabeloop include Antagene, May Health, and Biotypage.

Is Diabeloop hiring?

Yes. Diabeloop has 4 open roles listed on Vanberra Signal.